6+ hour, 23+ min ago   (12+ words) CHOSUNBIZ Chosunbiz...

23+ min ago   (358+ words) Backlash grows as Choo Mi-ae defends ending postpartum aid to safeguard meals and disability support Gyeonggi Gov. Choo Mi-ae said the decision to end Gyeonggi Province's postpartum care subsidy program was an unavoidable choice given fiscal conditions. She explained that…...

2+ hour, 13+ min ago   (183+ words) Actor Zin Taihyun returned to the half marathon a year after thyroid cancer surgery. That day, Zin Taihyun said, "My wife ran 10k, and maybe because she is currently in training to raise her condition she felt a lot of strain…...

7+ hour, 12+ min ago   (163+ words) New pre-PS tracks in math, life science, and social science to build early research skills Yonsei University College of Medicine will launch a curriculum that allows students to build fundamentals and research capacity from the premedical stage to train physician-scientists....

2+ day, 6+ hour ago   (510+ words) Data request over rat-only metabolite pauses new enrollment as SK Biopharm eyes fall clearance SK Biopharmaceuticals(326030)'s epilepsy drug candidate "Opacalim (BHV-7000)" received a partial clinical hold from the U.S. Food and Drug Administration (FDA), and the company said it expects…...

2+ day, 7+ hour ago   (244+ words) Phase 2 to test dosing and immune response in adults as company eyes homegrown mRNA capacity by 2028 GCBiopharma will enter phase 2 of a coronavirus messenger ribonucleic acid (mRNA) vaccine candidate it is developing in-house. It plans to begin dosing the first…...

2+ day, 10+ hour ago   (708+ words) Big drugmakers double down on next‑gen immunology, from long-lasting antibodies to AI-guided discovery Global big pharma (large drugmakers) are opening their wallets one after another to secure new drugs for immune diseases. U.S. drugmaker AbbVie acquired an immunology biotech…...